Korro Bio is led by Dr. Ram Aiyar, who serves as the President and Chief Executive Officer, guiding the biopharmaceutical enterprise through clinical research and corporate development milestones. Under his executive leadership, the company focuses on pioneering advanced genetic medicines through its proprietary RNA editing platform. He brings extensive operational experience in the biotechnology and life sciences sectors to his role, overseeing strategic collaborations, scientific research pipelines, and capital allocation initiatives designed to advance targeted RNA therapies from preclinical development toward clinical trial applications for rare and prevalent diseases.